Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Pulse Pressure Variation Helps to Predict Fluid Responsiveness in Patients Ventilated With Low Tidal Volumes

2. April 2012 aktualisiert von: Hospital de Clinicas de Porto Alegre

Objective: To determine the value of pulse pressure variation (ΔRESPPP) to predict fluid responsiveness in patients ventilated with low tidal volumes (VT), and to investigate whether a lower ΔRESPPP cut-off point should be used when patients are ventilated with low tidal volumes.

Methods: This cross-sectional, observational study included 37 critically ill patients with acute circulatory failure requiring fluid challenge. They were sedated and mechanically ventilated with Tidal Volume (VT) 6-7 ml/kg IBW (ideal body weight), monitored by pulmonary artery catheter and arterial line. Mechanical ventilation and hemodynamic parameters, including ΔRESPPP, were measured before and after fluid challenge with 1,000 ml crystalloids or 500 ml colloids. Fluid responsiveness was defined as an increase of at least 15% in cardiac index.

The present study was designed to (1) determine the value of ΔRESPPP to predict fluid responsiveness in patients ventilated with low tidal volumes, and (2) to investigate whether a lower ΔRESPPP cut-off point should be used when patients are ventilated with low tidal volumes.

The study hypothesis is not a good predictor of fluid responsiveness in patients ventilated with low tidal volumes.

Studienübersicht

Status

Abgeschlossen

Detaillierte Beschreibung

Volume expansion is frequently used to treat critically ill patients with acute circulatory failure. The goal of volume expansion is to increase left ventricular stroke volume and consequently cardiac output. However, about 50% of patients with acute circulatory failure will respond to fluid challenge (preload- dependent patients). Therefore, the ability to predict fluid responsiveness in critically ill patients is crucial, particularly for ARDS patients because of increased alveolar-capillary membrane permeability, and avoiding unnecessary fluid loading has been shown to have a positive effect on patient outcome.Among the dynamic parameters used at the bedside to identify fluid responsiveness, pulse pressure variation (ΔRESPPP) is one of the most accurate in patients with acute circulatory failure receiving invasive mechanical ventilation. However, most studies evaluated patients ventilated with large tidal volumes (≥ 8 ml/kg). Therefore, the validity of ΔRESPPP to identify fluid responsiveness is still debated when lower tidal volumes are used.

The current literature about its performance during ventilation with low tidal volumes is unclear, and opposite conclusions have been drawn. The present study was designed to (1) determine the value of ΔRESPPP to predict fluid responsiveness in patients ventilated with low tidal volumes, and (2) to investigate whether a lower ΔRESPPP cut-off point should be used when patients are ventilated with low tidal volumes.

Methods: This cross-sectional, observational study included 37 critically ill patients with acute circulatory failure requiring fluid challenge. They were sedated and mechanically ventilated with Tidal Volume (VT) 6-7 ml/kg IBW (ideal body weight), monitored by pulmonary artery catheter and arterial line. Mechanical ventilation and hemodynamic parameters, including ΔRESPPP, were measured before and after fluid challenge with 1,000 ml crystalloids or 500 ml colloids. Fluid responsiveness was defined as an increase of at least 15% in cardiac index.

Patients were followed for 28 days or until discharge from the ICU.

Study Protocol Patients were sedated with midazolan and fentanyl (score of -4 to -5 in the Richmond Agitation Sedation Scale)and ventilated in controlled pressure or controlled volume mode (Servo I system v.12 or Servo 900 C, Siemens, Sweden) with VT < 8 ml/kg IBW (51 + 0.9[height in cm- 152.9] for men and 45.5 + 0.91[height in cm- 152.9] for women). Ventilatory and hemodynamic variables were measured before and after FC with the patients in a supine position. Zero pressure was measured at the midaxillary line. The correct position of the pulmonary artery catheter in West's zone 3 was checked as described in the literature.

Fluid challenge was performed with 1000 ml 0.9% saline solution or lactated Ringer's solution (n=36) or 500 ml hydroxy-ethyl-starch solution 6% 130/0.4 for 30 minutes (n=2).

Hemodynamic Parameters

Variations in arterial pulse pressure were visualized on bedside monitors (HP S66 and PHILIPS IntelliVue, MP60, Germany) and measured with the cursor for each of 5 breathing cycles. ΔRESPPP was calculated using the following equation:

ΔRESPPP (%) = 100 x (PPmax - PPmin) / [(PPmax + PPmin)/2]

where PPmax and PPmin are the maximal pulse pressure at inspiration and the pulse pressure obtained on expiration, respectively.

A pulmonary artery catheter (Edwards Healthcare, Irvine, CA) was used to measure cardiac output according to the thermal dilution method (3 injections of 10ml 0.9% saline solution), systolic, diastolic and mean pulmonary arterial pressures, pulmonary artery occlusion pressure (PAOP, mmHg), central venous pressure (CVP, mmHg), and mixed venous saturation (SvO2). Mean arterial pressure (MAP, mmHg), measured using the arterial line, and heart rate (HR, bpm) were also recorded. All measurements were made at the end of expiration, before and after FC. Patients were defined as fluid responders when cardiac index increased at least 15% of baseline value.

Ventilation Parameters The following ventilatory parameters were measured: inspiratory and expiratory tidal volume, respiratory rate (RR), plateau pressure (cmH2O), peak pressure (cmH2O), total positive end-expiratory pressure (PEEPtot), static compliance (Cst) and driving pressure (DP= Pplat-PEEP). All measurements were made before and after FC.

Statistical Analysis Sample size was defined as 38 patients for estimation of the correlation between CI and ΔRESPPP 0.5 (moderate to high magnitude), with a level of significance of 0.05 and power of 90%.

The effects of FC on hemodynamic parameters were assessed using a paired Student's t-test for normally distributed variables or a nonparametric Wilcoxon Signed Rank test for non-normally distributed variables. The comparison of hemodynamic parameters between both groups at baseline and after FC was assessed using a two sample Student's t-test or a nonparametric Mann-Whitney U test. Results were expressed as mean values±SD or median (25-75 percentiles).

Receiver operating characteristic (ROC) curves were constructed to evaluate the ability of ΔRESPPP, ΔRESPPP/DP, CVP and PAOP to predict fluid responsiveness. The best cut-off value for ΔRESPPP ROC curve was determined for the entire population. In addition, measures of diagnostic performance were calculated: sensitivity, specificity, predictive values and likelihood ratio. Linear correlations were tested using the Spearman rank method. Data were analyzed using SPSS 15.0. A p value <0.05 was considered significant.

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

38

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brasilien, 90035903
        • Hospital de Clínicas de Porto Alegre

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

16 Jahre und älter (Kind, Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Wahrscheinlichkeitsstichprobe

Studienpopulation

Patients age ≥ 16 years, from both genders, admitted to the HCPA ICU, receiving invasive mechanical ventilation, with hemodynamic instability defined as need for norepinephrine infusion and/or intravascular fluid administration to maintain systolic arterial blood pressure > 90 mm Hg; with arterial line in place (radial or femoral) and pulmonary arterial catheter in place.

Beschreibung

Inclusion Criteria:

  • Age ≥ 16 years
  • Hemodynamic instability defined as need for norepinephrine infusion and/or intravascular fluid administration to maintain systolic arterial blood pressure > 90 mm Hg
  • Arterial line in place (radial or femoral)
  • Pulmonary arterial catheter in place

Exclusion Criteria:

  • Presence of cardiac arrhythmias
  • Presence of pneumothorax
  • Presence of heart valve disease or intracardiac shunt
  • Previously diagnosed right ventricular insufficiency

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: Kohorte
  • Zeitperspektiven: Querschnitt

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Increase in cardiac index at least 15% of baseline value.
Zeitfenster: Cardiac index was measured at the end of a 30 minutes fluid challenge.
Patients were sedated and ventilated in controlled pressure or controlled volume mode (Servo I system v.12 or Servo 900 C, Siemens, Sweden) with VT < 8 ml/kg ideal body weight. Ventilatory and hemodynamic variables were measured before and after FC with the patients in a supine position. Fluid challenge was performed with 1000 ml 0.9% saline solution or lactated Ringer's solution or 500 ml hydroxy-ethyl-starch solution 6% 130/0.4 for 30 minutes. The increase in cardiac index was measured immediately after fluid challenge.
Cardiac index was measured at the end of a 30 minutes fluid challenge.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Mortality
Zeitfenster: 28 days
Patients were followed for 28 days or until ICU discharge
28 days

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Gilberto Friedman, Hospital de Clínicas de Porto Alegre

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. Mai 2006

Primärer Abschluss (Tatsächlich)

1. Oktober 2009

Studienabschluss (Tatsächlich)

1. Oktober 2009

Studienanmeldedaten

Zuerst eingereicht

14. März 2012

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

2. April 2012

Zuerst gepostet (Schätzen)

3. April 2012

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Schätzen)

3. April 2012

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

2. April 2012

Zuletzt verifiziert

1. März 2012

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 06-109

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren